Literature DB >> 34075294

Tocilizumab cost effective in reducing COVID-19-related deaths.

.   

Abstract

Entities:  

Year:  2021        PMID: 34075294      PMCID: PMC8159658          DOI: 10.1007/s40274-021-7751-7

Source DB:  PubMed          Journal:  PharmacoEcon Outcomes News        ISSN: 1173-5503


× No keyword cloud information.
  1 in total

1.  Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality.

Authors:  Pranay Sinha; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

  1 in total
  1 in total

1.  Countering COVID-19 Vaccine Hesitancy in Pregnancy: the "4 Cs".

Authors:  Lydia L Shook; Thomas P Kishkovich; Andrea G Edlow
Journal:  Am J Perinatol       Date:  2021-10-19       Impact factor: 3.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.